chr4-48510949-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015030.2(FRYL):c.8181G>T(p.Glu2727Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,612,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015030.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRYL | NM_015030.2 | c.8181G>T | p.Glu2727Asp | missense_variant | 58/64 | ENST00000358350.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRYL | ENST00000358350.9 | c.8181G>T | p.Glu2727Asp | missense_variant | 58/64 | 5 | NM_015030.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000157 AC: 39AN: 248434Hom.: 0 AF XY: 0.000134 AC XY: 18AN XY: 134748
GnomAD4 exome AF: 0.0000384 AC: 56AN: 1460200Hom.: 0 Cov.: 29 AF XY: 0.0000330 AC XY: 24AN XY: 726448
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.8181G>T (p.E2727D) alteration is located in exon 58 (coding exon 55) of the FRYL gene. This alteration results from a G to T substitution at nucleotide position 8181, causing the glutamic acid (E) at amino acid position 2727 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at